Literature DB >> 671230

Linear systems analysis in pharmacokinetics.

D J Cutler.   

Abstract

Mesh：

Substances：

Year:  1978        PMID： 671230     DOI： 10.1007/BF01312266

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  8 in total

1.  Do you need a pharmacokinetic model, and, if so, which one?

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1975-12

2.  Theoretical and computational basis for drug bioavailability determinations using pharmacological data. II. Drug input in equilibrium to response relationships.

Authors:  V F Smolen
Journal:  J Pharmacokinet Biopharm       Date:  1976-08

3.  Theoretical and computational basis for drug bioavailability determinations using pharmacological data. I. General considerations and procedures.

Authors:  V F Smolen
Journal:  J Pharmacokinet Biopharm       Date:  1976-08

4.  Pitfalls in digital computation of the impulse response of vascular beds from indicator-dilution curves.

Authors:  J Gamel; W F Rousseau; C R Katholi; E Mesel
Journal:  Circ Res       Date:  1973-04       Impact factor: 17.367

5.  Properties of the Michaelis-Menten equation and its integrated form which are useful in pharmacokinetics.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1973-04

6.  General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics.

Authors:  L Z Benet
Journal:  J Pharm Sci       Date:  1972-04       Impact factor: 3.534

7.  Numerical deconvolution by least squares: use of polynomials to represent the input function.

Authors:  D J Cutler
Journal:  J Pharmacokinet Biopharm       Date:  1978-06

8.  Numerical deconvolution by least squares: use of prescribed input functions.

Authors:  D J Cutler
Journal:  J Pharmacokinet Biopharm       Date:  1978-06
  8 in total
  30 in total

1.  Indirect pharmacodynamic models for responses with multicompartmental distribution or polyexponential disposition.

Authors:  W Krzyzanski; W J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-02       Impact factor: 2.745

2.  Absorption kinetics after inhalation of fluticasone propionate via the Diskhaler, Diskus and metered-dose inhaler in healthy volunteers.

Authors:  C Brindley; C Falcoz; A E Mackie; A Bye
Journal:  Clin Pharmacokinet       Date:  2000       Impact factor: 6.447

3.  Fundamental pharmacokinetic limits on the utility of using a sinusoidal drug delivery system to enhance therapy.

Authors:  R R Burnette
Journal:  J Pharmacokinet Biopharm       Date:  1992-10

Review 4.  Noncompartmental versus compartmental modelling in clinical pharmacokinetics.

Authors:  W R Gillespie
Journal:  Clin Pharmacokinet       Date:  1991-04       Impact factor: 6.447

5.  Pharmacokinetic evaluation of stable piecewise cubic polynomials as numerical integration functions.

Authors:  K C Yeh; R D Small
Journal:  J Pharmacokinet Biopharm       Date:  1989-12

6.  Evaluation of hepatic function using the pharmacokinetics of a therapeutically administered drug. Application to the immunosuppressant cyclosporin.

Authors:  W Weber; M Looby; J Brockmöller
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

7.  Erythropoietin pharmacokinetic/pharmacodynamic analysis suggests higher doses in treating neonatal anemia.

Authors:  Srividya Neelakantan; John A Widness; Robert L Schmidt; Peter Veng-Pedersen
Journal:  Pediatr Int       Date:  2009-02       Impact factor: 1.524

8.  Application of a linear recirculation model to drug targeting.

Authors:  A V Boddy; L J Aarons
Journal:  J Pharmacokinet Biopharm       Date:  1991-06

9.  Pharmacokinetic differentiation of drug candidates using system analysis and physiological-based modelling. Comparison of C.E.R.A. and erythropoietin.

Authors:  Peter Veng-Pedersen; Kevin J Freise; Robert L Schmidt; John A Widness
Journal:  J Pharm Pharmacol       Date:  2008-10       Impact factor: 3.765

10.  The use of mass balance principles to describe regional drug distribution and elimination.

Authors:  R N Upton; L E Mather; W B Runciman; C Nancarrow; R J Carapetis
Journal:  J Pharmacokinet Biopharm       Date:  1988-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.